
Padlas-L Plus 80mg/480mg Tablet
Marketer
Aden Healthcare
Salt Composition
Artemether (80mg) + Lumefantrine (480mg)
Overview Padlas-L Plus 80mg/480mg Tablet
Malarone Plus 80mg/480mg tablets effectively combat malaria in patients of all ages. This dual-action antimalarial medication targets and eliminates the malaria parasite, halting infection progression. However, it's crucial to understand that it's solely for treating existing malaria, not for prevention or severe cases impacting vital organs like the brain, lungs, or kidneys. Optimal absorption is achieved when taken with food. Always adhere to your physician's prescribed dosage and duration; exceeding the recommended amount can be detrimental. Finish the entire course to ensure complete eradication of the infection. Common side effects may include headache, appetite loss, fatigue, arthralgia, and myalgia; dizziness is also possible. Report any persistent or worsening symptoms to your doctor. Prior to commencing treatment, disclose all other medications you're currently using. Use during pregnancy or breastfeeding requires explicit medical consultation due to potential fetal harm.
Uses of Padlas-L Plus 80mg/480mg Tablet
Managing Malaria Infections
Major Benefits of Padlas-L Plus 80mg/480mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for Padlas-L Plus 80mg/480mg Tablets. Ingest the tablets whole; avoid chewing, crushing, or breaking them. Administer this medication with a meal.
Common Side effects of Padlas-L Plus 80mg/480mg Tablet:
- Headache
- Loss of appetite
- Dizziness
- Weakness
- Joint pain
- Muscle pain
How to use Padlas-L Plus 80mg/480mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for Padlas-L Plus 80mg/480mg Tablets. Ingest the tablet whole; avoid crushing, chewing, or breaking it. Administer this medication with a meal.
How Padlas-L Plus 80mg/480mg Tablet works:
Artemether and Lumefantrine, combined as Padlas-L Plus 80mg/480mg tablets, offer effective malaria treatment. Their mechanism involves elevating blood haeme levels, a substance harmful to the malaria parasite. This heightened toxicity eradicates the parasite, thereby halting the infection's progression.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
The interaction of alcohol with Padlas-L Plus 80mg/480mg Tablet is undetermined. Physician consultation is recommended.
PregnancyCONSULT YOUR DOCTOR
The use of Padlas-L Plus 80mg/480mg tablets during pregnancy may pose risks. While human research is limited, animal studies indicate potential harm to a developing fetus. A physician will assess the potential benefits against any risks prior to prescribing this medication. Seek medical advice before use.
Breast feedingSAFE IF PRESCRIBED
The use of Padlas-L Plus 80mg/480mg tablets while breastfeeding is likely safe. Available human data indicates minimal risk to the infant.
DrivingUNSAFE
Taking Padlas-L Plus 80mg/480mg tablets might reduce alertness, impair vision, or cause drowsiness and dizziness. Refrain from driving if you experience these effects.
KidneyCAUTION
Patients with severe kidney impairment should exercise caution when using Padlas-L Plus 80mg/480mg tablets. Dosage modification for Padlas-L Plus 80mg/480mg tablets may be necessary; physician consultation is advised. Severe renal dysfunction does not necessitate a dosage change.
LiverCAUTION
Exercise caution when administering Padlas-L Plus 80mg/480mg tablets to individuals with severe hepatic impairment. Dosage modification for Padlas-L Plus 80mg/480mg tablets might be necessary. Physician consultation is advised. Dosage alteration is not typically advised for patients exhibiting severe liver dysfunction.
What if you forget to take Padlas-L Plus 80mg/480mg Tablet :
Should you forget a Padlas-L Plus 80mg/480mg Tablet dose, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Padlas-L Plus 80mg/480mg Tablet
| Label | Value |
|---|---|
| Addictive | None. |
| Medication Classification | Antimalarial medications |
